Introduction to (e)COA and (e)PRO

This course is ideal for Clinical Data Managers, Clinical Trial Managers, Project Managers, Vendor Managers, biometrics professionals, and clinical operations or CRO staff who design, manage, or oversee (e)COA and (e)PRO components in clinical trials.

It is particularly relevant for professionals working in sponsor organisations, CROs, or specialist (e)COA vendors who want a structured understanding of how patient-reported and clinician-reported outcomes fit into modern trial design and conduct.

Yes, a foundational understanding of clinical trials and clinical data management is expected.

This is a beginner-to-intermediate module focused on the practical realities of (e)COA and (e)PRO. Participants should already be familiar with clinical development processes and basic data management activities. No prior (e)COA or (e)PRO experience is required, but basic clinical research knowledge is necessary.

Estimated learning time is approximately 4–8 hours, depending on your pace and background.

Yes! Once enrolled, you can access all course materials at any time and progress at your own pace. There are no deadlines or live sessions required.

Yes! Upon completing the course content and passing the certification test, you'll receive a certificate of completion. Note: The certificate supports professional development but is not a license or regulatory credential.

This is a highly practical course.

While definitions and validated-instrument principles are covered, the focus is on how (e)COA and (e)PRO decisions play out in real trials — including supervised vs unsupervised collection, paper vs electronic capture, BYOD vs provisioning, compliance measurement, and operational basics across start-up, conduct, and close-out.

The content is designed to be directly applicable in sponsor, CRO, and specialist (e)COA vendor environments.

Yes. The course is anchored in the FDA PRO guidance and addresses the practical implications of validated instruments, licensing, electronic implementation, and the difference between live data and source data.

It translates regulatory principles into design decisions, operational choices, and compliance practices that can be implemented in real (e)COA and (e)PRO programmes.

Most CDM courses focus on traditional eCRF-based data management — CRF design, edit checks, data cleaning, and database lock.

This course focuses on (e)COA and (e)PRO — a distinct and growing area of clinical data where the patient (or clinician or observer) is the source, where data is mostly live, and where the design and operational choices reshape what data quality and compliance even mean.

Rather than teaching general CDM principles, this module gives you a structured understanding of (e)COA and (e)PRO as a discipline — from validated instruments and licensing to compliance, parking-lot syndrome, recall bias, and operational best practice.

This course supports professionals aiming for or currently working in roles such as Clinical Data Manager, Clinical Trial Manager, Project Manager, Vendor Manager, biometrics professional, or (e)COA/(e)PRO specialist.

It strengthens competencies in patient-reported data design, validated instruments, compliance measurement, and operational (e)COA management — skills that are increasingly critical as patient-subjective endpoints become more central to regulatory and payer decisions.

The structured framework provided in this module helps you move from general CDM contributor to a confident contributor on (e)COA and (e)PRO components of any trial.

Yes. The module covers the trade-offs between paper and electronic capture in detail, including patient compliance, data quality, parking-lot syndrome, recall bias, regulatory acceptability, and operational cost — so you can contribute confidently to the design decision.

Yes. BYOD vs provisioning is one of the key scenarios covered in Chapter 2. The module walks through what each model means for sites, patients, and the trial, when to choose one over the other, and how to plan for fallback when something doesn't work as expected.

Yes. Validated instruments are covered in depth — what they are, why they matter, when to use them, how licensing works, and the rule of thumb for using them in trials. The module also addresses what to do when no validated instrument fits, anchored in FDA PRO guidance.